Ambrisentan Tablet, Film Coated
Product Images NDC 0378-4270
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ambrisentan (NDC 0378-4270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2: Effects Of Other Drugs On Ambrisentan Pharmacokinetics (Image 02)
Figure 3: Effects Of Ambrisentan On Other Drugs (Image 03)
Figure 4 Mean Change In 6-minute Walk Distance (aries-1 And Aries-2) (Image 04)
Figure 5 Time To Clinical Worsening (aries-1 And Aries-2) (Image 05)
Acceptable Birth Control Options (Image 06)
Ambrisentan Tablets 5 mg Bottle Label (Image 07)
Ambrisentan Tablets 10 mg Bottle Label (Image 08)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.